These observations suggest that vorasidenib, through the restoration of mitochondrial metabolism and suppression of 2-HG accumulation, may enhance PpIX production and improve intraoperative visualization in IDH-mutant gliomas, which are relatively resistant to 5-ALA-induced fluorescence. Here, IDH1 is linked to central nervous system cancer.